{
  "nctId": "NCT01501955",
  "briefTitle": "The Metaphyseal Hip Prosthesis - Total Hip",
  "officialTitle": "Evaluation of the Safety and Efficiency of the Metaphyseal Hip Prosthesis - Total Hip Arthroplasty",
  "protocolDocument": {
    "nctId": "NCT01501955",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-06-18",
    "uploadDate": "2024-09-05T07:45",
    "size": 220206,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT01501955/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 20,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2012-10",
    "completionDate": "2023-12",
    "primaryCompletionDate": "2016-01",
    "firstSubmitDate": "2011-08-26",
    "firstPostDate": "2011-12-30"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Candidates for a total hip replacement because of arthritis of the hip\n* Patients with a good general condition\n* Patients willing and able to participate in the clinical trial with a 10 years follow up and who have signed an inform consent\n* Males and females\n* Age between 55 and 75\n* Absence or little presence of osteoporotic bone (t\\>-2)\n* ASA score 1 and 2\n\nExclusion Criteria:\n\n* Patient with co morbidities that limit the physical abilities which may negatively influence the scores. Such co morbidities can for example be cardiac insufficiency or chronic respiratory diseases.\n* Severe systematic diseases such as rheumatic arthritis and SLE.\n* General osteoporosis (t\\<-2).\n* Hormonal conditions such as Paget disease, which reduces the bone density.\n* Diseases that can negatively influence the 10 years life expectancy.\n* Chronic use of corticosteroids.\n* Extreme overweight defined as BMI above 35.\n* Active bacterial infection.\n* Mental weakness which could negatively influence the postoperative recovery and influence the ability to complete pain scores and other questionnaires.\n* ASA score \\>2.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "55 Years",
    "maximumAge": "75 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "RSA Translation X",
        "description": "Stem movement measured with RSA (radiostereometric analysis) along the x-axis in mm. RSA is a technique to accurately measure 3D movement of the prosthesis in the bone. The movement is measured with respect to the situation directly postoperative.",
        "timeFrame": "3 months, 6 months, 1 year and 2 years postoperatively"
      },
      {
        "measure": "RSA Translation Y",
        "description": "Stem movement along the y-axis in mm. (measured with RSA)",
        "timeFrame": "3 months, 6 months, 1 year and 2 years postoperatively"
      },
      {
        "measure": "RSA Translation Z",
        "description": "Stem movement along z-axis in mm (measured with RSA)",
        "timeFrame": "3 months, 6 months, 1 year and 2 years postoperatively"
      },
      {
        "measure": "RSA Rotation X",
        "description": "Stem Rotation around X-axis in degrees (measured with RSA)",
        "timeFrame": "3 months, 6 months, 1 year and 2 years postoperatively"
      },
      {
        "measure": "RSA Rotation Y",
        "description": "Stem rotation around the y-axis in degrees ( measured with RSA)",
        "timeFrame": "3 months, 6 months, 1 year and 2 years postoperatively"
      },
      {
        "measure": "RSA Rotation Z",
        "description": "Stem rotation around the z-axis in degrees (measured with RSA)",
        "timeFrame": "3 months, 6 months, 1 year and 2 years postoperatively"
      },
      {
        "measure": "RSA MTMP",
        "description": "Maximum Total Point Motion (MTPM) measured with RSA. This is a mean for the total migration of the stem.",
        "timeFrame": "3 months, 6 months, 1 year and 2 years postoperatively"
      }
    ],
    "secondary": [
      {
        "measure": "Number of Reported Device Related Complications",
        "description": "Safety:\n\n\\- Frequency of serious device related complications.",
        "timeFrame": "6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, 10 years postoperatively"
      },
      {
        "measure": "Harris Hip Score",
        "description": "Harris Hip Score (HHS), a score to measure health and satisfaction after a hip prosthesis.\n\nThe score has a maximum of 100 points (best possible outcome) covering pain (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 4 points), and range of motion (2 items, 5 points)",
        "timeFrame": "pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively"
      },
      {
        "measure": "DEXA",
        "description": "Efficacy: Bone density measured using the average DEXA score in each zone. For the long Stanmore the 7 Gruen zones were defined. For the short MHP stem an adjusted model with only 5 zones was used. The scan at 6 weeks is used as the baseline measurement to analyze if the bone density changes in the following years. At 1 year and 2 year follow up, percentual change is presented for both groups with respect to the 6 weeks DEXA score",
        "timeFrame": "1 and 2 years postoperative"
      },
      {
        "measure": "HOOS-Pain Subscale",
        "description": "HOOS (Hip disability and Osteoarthritis Outcome Score) consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.",
        "timeFrame": "pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively"
      },
      {
        "measure": "HOOS-Symptom Subscale",
        "description": "HOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.",
        "timeFrame": "pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively"
      },
      {
        "measure": "HOOS-ADL Subscale",
        "description": "HOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.",
        "timeFrame": "pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively"
      },
      {
        "measure": "HOOS-Sport Subscale",
        "description": "HOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.",
        "timeFrame": "pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively"
      },
      {
        "measure": "HOOS-QoL Subscale",
        "description": "HOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and hip related Quality of life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.",
        "timeFrame": "pre-operatively, 6 weeks, 3 months, 6 months, 1,2, 3, 4, 5, 6, 7, and 10 years postoperatively"
      },
      {
        "measure": "SF-12 Physical Summary Score",
        "description": "12-Item Short-Form Health Survey (SF-12) presented in Physical (PS) and Mental summary (MS) scores (range 0-100).\n\nA zero score indicates the lowest level of health and 100 indicates the highest level of health.",
        "timeFrame": "pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively"
      },
      {
        "measure": "SF-12 Mental Summary Score",
        "description": "SF-12 Score presented in Physical and Mental summary scores (range 0-100). A zero score indicates the lowest level of health and 100 indicates the highest level of health.",
        "timeFrame": "pre-operatively, 6 weeks, 3 months, 6 months, 1, 2, 3, 4, 5, 6, 7, and 10 years postoperatively"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 7,
      "secondaryCount": 10,
      "otherCount": 0,
      "totalCount": 17
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:57.423Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}